TABLE 1.
Baseline Characteristics (N = 150)
Characteristic | Results |
---|---|
Age, mean (SD), y | 69.5 (9.7) |
| |
Sex, No. (%) | |
Male | 142 (94.7) |
Female | 8 (5.3) |
| |
Race, White, No. (%) | 134 (89.3) |
| |
Medications, No. (%) | |
Insulin | 150 (100) |
Sodium-glucose cotransporter 2-inhibitors | 28 (18.7) |
Glucagon-like peptide-1 inhibitors | 17 (11.3) |
Biguanides | 70 (46.7) |
Dipeptidyl peptidase-4 inhibitors | 11 (7.3) |
Thiazolidinediones | 6 (4.0) |
Sulfonylureas | 4 (2.7) |